Glenmark

PRESENTATION OF FINANCIAL AND OTHER INFORMATION
Our financial statements included in this Preliminary Placement Document have been prepared in
accordance with Indian GAAP. Indian GAAP differs in certain significant respects from USGAAP and
IFRS. The Company does not provide a reconciliation of its financial statements to US GAAP and IFRS.
Also see “Risk Factors – Risks Factors Related to India - Significant differences exist between Indian
Generally Accepted Accounting Principles (“Indian GAAP”) and other accounting principles, such as US
Generally Accepted Accounting Principles (“US GAAP”) and International Financial Reporting Standards
(“IFRS”), which may be material to investors’ assessments of our financial condition”. In this Preliminary
Placement Document, certain monetary amounts have been subject to rounding adjustments; accordingly,
figures shown as totals in certain tables may not be an arithmetic aggregation of figures which precede
them.
Unless stated otherwise, the financial data in this Preliminary Placement Document is derived from our
consolidated financial statements prepared in accordance with Indian GAAP. Our Fiscal Year commences
on April 1 of each year and ends on March 31 of the succeeding year, so all references to a particular Fiscal
Year of the Company are to the twelve-month period ended on March 31 of that year.
All references to “us”, “we” and “our” are to Glenmark Pharmaceuticals Limited and its subsidiaries on a
consolidated basis, unless otherwise stated.
All references to “you”, “offeree”, “purchasers”, “subscriber”, “recipient”, “investors” are to prospective
investors in the Equity Shares. References in this Preliminary Placement Document to “India” are to the
Republic of India and the “Government” are to the governments in India, central or state, as applicable.
EXCHANGE RATES
The Company prepares and publishes its financial statements in Rupees. All references to “Rupees” and
“Rs.” are to Indian Rupees and all references to “US Dollars” and “US$” are to United States Dollars. The
following table sets forth, for the periods indicated, information with respect to the exchange rate between
the Rupee and the U.S. Dollar (in Rupees per U.S. Dollar) based on the reference rates released by the RBI.
The exchange rate as at March 31, 2009 was Rs. 50.95 = U.S. $1.00 and as at September 9, 2009 was Rs.
48.47 = U.S. $1.00. (Source: www.rbi.org.in).
Exchange rate (Rs. Per U.S.$ 1.00)
Year/ Period Period End Average High Low
Year ended 2007 43.59 45.29 46.95 43.14
Year ended 2008 39.97 40.24 43.15 39.27
Year ended 2009 50.95 45.91 52.06 39.89
Three months ended June 30, 2009 47.87 48.67 50.53 46.84
Source: www.rbi.org.in
No representation is made that the Rupee amounts actually represent such amounts in U.S. Dollars or could
have been or could be converted into U.S. Dollars at the rates indicated, any other rates or at all.
INDUSTRY AND MARKET DATA
Market data and certain industry forecasts used throughout this Preliminary Placement Document have
been obtained from market research, publicly available information and industry publications. Industry
publications generally state that the information that they contain has been obtained from sources believed
to be reliable but that the accuracy and completeness of that information is not guaranteed. Similarly,
internal surveys, industry forecasts and market research, while believed to be reliable, have not been
independently verified and neither the Company not the Joint Global Coordinators and Book Running Lead
Managers makes any representation as to the accuracy and completeness of that information.
i